{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antioxidant", "Cytotoxicity", "Nitric oxide", "Pro-inflammatory markers", "Raw 264.7 cells", "TNF-\u03b1"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29957472", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "18"}, "DateRevised": {"Year": "2019", "Month": "01", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "06", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2018.06.053", "S0753-3322(18)30351-2"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "106", "PubDate": {"Year": "2018", "Month": "Oct"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Antioxidant and anti-inflammatory properties of marmelosin from Bael (Aegle marmelos L.); Inhibition of TNF-\u03b1 mediated inflammatory/tumor markers.", "Pagination": {"StartPage": "98", "EndPage": "108", "MedlinePgn": "98-108"}, "Abstract": {"AbstractText": ["Oxidative stress and inflammation are important critical factors that are implicated in almost all life style disorders such as diabetes, cardiovascular disease, ulcer and cancer. Current study aimed at isolation and characterization of a furanocoumarin from Bael (Aegle marmelos L.) fruit that can modulate both oxidative stress and inflammation effectively. Ethyl acetate extract of Bael fruit (EAFB) was subjected to HPLC for identification, purified and characterized using FTIR, NMR and ESI-MS analysis. Predominant peak of EAFB at RT 12.54\u202fmin on HPLC was identified as marmelosin with molecular weight of m/z \u223c 271.2. Marmelosin was evaluated for antioxidant, antiproliferative, apoptotic, cancer (Tyrosinase & Galectin-3) and immunomodulatory (NO, TNF-\u03b1) potentials employing standard assay systems. Marmelosin possessed potent antioxidant activity with IC<sub>50</sub> of \u223c 15.4\u202f\u00b1\u202f0.32 \u03bcM as opposed to standard - gallic acid (IC<sub>50</sub> 1.1\u202f\u00b1\u202f0.08 \u03bcM), antiproliferative activity with IC<sub>50</sub> of \u223c 6.24\u202f\u00b1\u202f0.16 \u03bcM as opposed to deferoxamine (\u223c10.8\u202f\u00b1\u202f0.28 \u03bcM) and protected cells against cellular/DNA damage. Anti-inflammatory property was evident with significant reduction in the release of NO (\u223c3.9 fold) and TNF-\u03b1 (\u223c3.4 fold), a pro-inflammatory cytokine, in addition to the inhibition of NF\u03baB (\u223c2.7 fold), a transcription factor in Raw 264.7 cells. Marked down regulation of galectin-3 (\u223c5.5 folds) and tyrosinase (\u223c11.1 folds) by gene expression analysis substantiated by tyrosinase inhibition (IC<sub>50</sub> - 20.3\u202f\u00b1\u202f1.26 \u03bcM Vs. Kojic acid - IC<sub>50</sub> - 24.1\u202f\u00b1\u202f1.41 \u03bcM) and molecular docking studies strengthened the cancer modulatory property of marmelosin. In addition, marmelosin induced apoptotic bodies, chromatin condensation and nulcear blebbing in Raw 264.7 cells commending the apoptotic effect of marmelosin. Marmelosin thus displayed potential multi-potent antioxidant, anti-inflammatory and anticancer properties via TNF-\u03b1 mediated Akt signaling pathway."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, Karnataka, India."}], "LastName": "Pynam", "ForeName": "Hasitha", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, Karnataka, India. Electronic address: shylaja@cftri.res.in."}], "LastName": "Dharmesh", "ForeName": "Shylaja M", "Initials": "SM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Furocoumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Galectin 3"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Lgals3 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "marmelosin"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.18.1", "NameOfSubstance": "Monophenol Monooxygenase"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Aegle"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Fibroblasts"}, {"QualifierName": [], "DescriptorName": "Fruit"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Furocoumarins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Galectin 3"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Monophenol Monooxygenase"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "NIH 3T3 Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "RAW 264.7 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "1", "Day": "16"}, {"Year": "2018", "Month": "6", "Day": "8"}, {"Year": "2018", "Month": "6", "Day": "12"}, {"Year": "2018", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29957472", "10.1016/j.biopha.2018.06.053", "S0753-3322(18)30351-2"]}}]}